98-30006. Blood Donor Suitability; Public Workshop  

  • [Federal Register Volume 63, Number 217 (Tuesday, November 10, 1998)]
    [Notices]
    [Page 63067]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-30006]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Blood Donor Suitability; Public Workshop
    
    AGENCY:  Food and Drug Administration, HHS.
    
    ACTION:  Notice.
    
    -----------------------------------------------------------------------
    
        The Food and Drug Administration (FDA) is announcing the following 
    public workshop: Blood Donor Suitability. The workshop is intended to 
    gather current scientific data on certain high risk criteria used in 
    donor deferral.
        Date and Time: The workshop will be held on Monday, November 23, 
    1998, 8:30 a.m. to 5 p.m.
        Location: The workshop will be held at the Parklawn Bldg., 
    conference rooms D and E, 5600 Fishers Lane, Rockville, MD 20857.
        Contact: Robbin Gordon, Project Manager, Conference Management 
    Associates, Inc., Three Corporate Sq., suite 180, Atlanta, GA 30329-
    2013, 404-633-9117, FAX 404-636-6311.
        Registration: Send or fax registration information (including name, 
    title, firm name, address, telephone, and fax number) to the contact 
    person by Friday, November 13, 1998.
        Registration at the site will be done on a space available basis on 
    the day of the workshop beginning at 7:30 a.m. There is no registration 
    fee for the workshop.
        If you need special accommodations due to disability, please 
    contact Carol White Hales at least 7 days in advance.
    Supplementary Information: The purpose of the workshop is to gather 
    current scientific data on certain blood donor suitability issues. At 
    the workshop, FDA will review the use of certain donor deferral 
    criteria based on high risk behavior (i.e., intravenous drug abuse, 
    male to male sex, and sex for drugs or money).
        Transcripts: Transcripts of the workshop may be requested in 
    writing from the Freedom of Information Office (HFI-35), Food and Drug 
    Administration, 5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857, 
    approximately 15 working days after the workshop at a cost of 10 cents 
    per page. The workshop transcript will also be available on the Center 
    for Biologics Evaluation and Research website at ``http://www.fda.gov/
    cber/minutes/workshop-min.htm''.
    
        Dated: November 2, 1998.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 98-30006 Filed 11-9-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
11/10/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
98-30006
Pages:
63067-63067 (1 pages)
PDF File:
98-30006.pdf